GIVEN DOUGLAS B 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
GIVEN DOUGLAS B
Director
Transactions
- Sale
Common Stock
2023-02-27$32.62/sh−875$28,542→ 13,000 total(indirect: By Trust)
Holdings
- 124,135
Common Stock
- 12,500(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents securities owned directly by Anne Given Trust ("AG Trust"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
- [F3]Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.